Senior insider sale
ENLIVEN THERAPEUTICS, INC. — senior position signals high conviction
$2.25M
38K shares
What this filing means
HEYMAN RICHARD A. plans to sell 38K shares of ENLIVEN THERAPEUTICS, INC. valued at approximately $2.25M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/4/2026ACC: 0001959173-26-006749
Director
Since Feb 2026
38K
Shares to sell
$2.25M
Approx. market value
38.06K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Stock Options Exercise
N/A
10/23/2020
15.42KRestricted Stock Purchase agreement
N/A
1/28/2020
22.65KTotal acquired38.06K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/23/2020 | Stock Options Exercise N/A | 15.42K | — |
1/28/2020 | Restricted Stock Purchase agreement N/A | 22.65K | — |
| Total | 38.06K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
38K
Market value
$2.25M
9/4/2026
Total
Units
38K
Value
$2.25M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/4/2026 | 38K | $2.25M | NASDAQ | Planned |
| Total | 38K | $2.25M | ||